Reference health

Design of Promising Thiazoloindazole-Based Acetylcholinesterase Inhibitors Guided by Molecular Docking and Experimental Insights

https://doi.org/10.1021/acschemneuro.4c00241
CiteStamped reference-health badge
64/64 checkable references clean · checked 2026-07-24

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

10 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 64 checked references that resolve
resolves10.1016/j.cbi.2010.01.042
Acetylcholinesterase: From 3D structure to function
resolves10.1016/j.arr.2022.101787
AChE as a spark in the Alzheimer’s blaze – Antagonizing effect of a cyclized variant
resolves10.3390/ph16020179
An Overview of 1,2,3-triazole-Containing Hybrids and Their Potential Anticholinesterase Activities
resolves10.1093/brain/awy132
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
resolves10.1159/000528886
Comprehensive Bibliometric Analysis of Stem Cell Research in Alzheimer’s Disease from 2004 to 2022
resolves10.1007/s11948-022-00422-0
A Review of Scientific Ethics Issues Associated with the Recently Approved Drugs for Alzheimer’s Disease
resolves10.1002/alz.12068
2020 Alzheimer's disease facts and figures
resolves10.1039/C6CC04341K
AgNO <sub>3</sub> as nitrogen source for rhodium( <scp>iii</scp> )-catalyzed synthesis of 2-aryl-2H-benzotriazoles from azobenzenes
resolves10.1212/WNL.0000000000008699
Risks and benefits of unapproved disease-modifying treatments for neurodegenerative disease
resolves10.3389/fneur.2021.654739
Immunotherapies for Neurodegenerative Diseases
resolves10.1038/s41598-022-21820-1
Disease stages and therapeutic hypotheses in two decades of neurodegenerative disease clinical trials
resolves10.3390/ijms232213954
Alzheimer’s Disease: Treatment Strategies and Their Limitations
resolves10.1159/000381546
The Treatment Strategies for Neurodegenerative Diseases by Integrative Medicine
resolves10.3390/ijms24032722
Natural Inhibitors of Cholinesterases: Chemistry, Structure–Activity and Methods of Their Analysis
resolves10.1080/07391102.2023.2230279
An insight into structure-activity relationship of naturally derived biological macromolecules for the treatment of Alzheimer’s disease: a review
resolves10.1016/j.pnpbp.2017.01.003
The pharmacology of tacrine at N -methyl- d -aspartate receptors
resolves10.1134/S1819712422040183
Molecular Mechanisms of Emerging Therapeutic Targets in Alzheimer’s Disease: A Systematic Review
resolves10.1016/j.ejphar.2003.11.080
Pharmacology of selective acetylcholinesterase inhibitors: implications for use in Alzheimer's disease
resolves10.1016/j.bioorg.2024.107152
A comprehensive review of multi-target directed ligands in the treatment of Alzheimer’s disease
resolves10.1007/s11011-022-00921-w
Alzheimer’s disease therapy based on acetylcholinesterase inhibitor/blocker effects on voltage-gated potassium channels
resolves10.3390/biom11030350
Acetylcholinesterase Inhibitory Potential of Various Sesquiterpene Analogues for Alzheimer’s Disease Therapy
resolves10.1111/jnc.15335
Ligand design for human acetylcholinesterase and nicotinic acetylcholine receptors, extending beyond the conventional and canonical
resolves10.1039/D2RA03081K
Inhibitory potential of nitrogen, oxygen and sulfur containing heterocyclic scaffolds against acetylcholinesterase and butyrylcholinesterase
resolves10.2174/1389450124666221213114500
A Review on Recent Development of Novel Heterocycles as Acetylcholinesterase Inhibitor for the Treatment of Alzheimer’s Disease
resolves10.2174/1389557522666220922105934
A Recent Appraisal of Small-Organic Molecules as Anti-Alzheimer’s Agents
resolves10.1002/ddr.21979
A review on synthetic strategy, molecular pharmacology of indazole derivatives, and their future perspective
resolves10.2174/1568026622666220512145646
Impact of Indazole Scaffold as Antibacterial and Antifungal Agent
resolves10.1039/D1RA03979B
Current progress, challenges and future prospects of indazoles as protein kinase inhibitors for the treatment of cancer
resolves10.1007/s00044-020-02665-7
Indazole scaffold: a generalist for marketed and clinical drugs
resolves10.1080/13543776.2018.1472240
Indazole derivatives and their therapeutic applications: a patent review (2013-2017)
resolves10.1016/j.molstruc.2022.133479
Thiazole derivatives in medicinal chemistry: Recent advancements in synthetic strategies, structure activity relationship and pharmacological outcomes
resolves10.33263/BRIAC122.21712195
Antibacterial Activity of Thiazole and its Derivatives: A Review
resolves10.2174/0929867329666220318100019
Thiazole and Related Heterocyclic Systems as Anticancer Agents: A Review on Synthetic Strategies, Mechanisms of Action and SAR Studies
resolves10.1016/j.biopha.2021.111495
Antiproliferative activity of thiazole and oxazole derivatives: A systematic review of in vitro and in vivo studies
resolves10.2174/1385272825999210101234704
An Insight into Synthesis and Anticancer Potential of Thiazole and 4-thiazolidinone Containing Motifs
resolves10.1016/j.ejmech.2019.112016
Thiazole-containing compounds as therapeutic targets for cancer therapy
resolves10.1016/j.tet.2008.05.009
An expedient, regioselective synthesis of novel 2-alkylamino- and 2-alkylthiothiazolo[5,4-e]- and -[4,5-g]indazoles and their anticancer potential
resolves10.1002/jhet.3253
Microwave‐Assisted Synthesis of Antimicrobial Agents Containing Carbazole and Thiazole Moieties
resolves10.1016/j.bioorg.2020.103994
New nitroindazole-porphyrin conjugates: Synthesis, characterization and antibacterial properties
resolves10.1002/slct.201904344
Synthesis and Biological Evaluation of New Functionalized Nitroindazolylacetonitrile Derivatives
resolves10.1039/C9NJ02807B
New nitroindazolylacetonitriles: efficient synthetic access <i>via</i> vicarious nucleophilic substitution and tautomeric switching mediated by anions
resolves10.1002/ejoc.202200262
Catalyst‐ and Oxidant‐Free Electrochemical Halogenation Reactions of 2<i>H</i>‐Indazoles with NaX (X=Cl, Br)
resolves10.1021/jm049223g
Indazole Estrogens:  Highly Selective Ligands for the Estrogen Receptor β
resolves10.1021/jo011148j
Peptidotriazoles on Solid Phase:  [1,2,3]-Triazoles by Regiospecific Copper(I)-Catalyzed 1,3-Dipolar Cycloadditions of Terminal Alkynes to Azides
resolves10.1186/s13321-018-0325-4
Large scale comparison of QSAR and conformal prediction methods and their applications in drug discovery
resolves10.1093/nar/gky1075
ChEMBL: towards direct deposition of bioassay data
resolves10.1021/jm300871x
Structures of Human Acetylcholinesterase in Complex with Pharmacologically Important Ligands
resolves10.1038/s41598-021-82410-1
New machine learning and physics-based scoring functions for drug discovery
resolves10.1039/D0RA02339F
Synthesis, acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) activities, and molecular docking studies of a novel compound based on combination of flurbiprofen and isoniazide
resolves10.1038/s41598-019-56463-2
Phenoxyethyl Piperidine/Morpholine Derivatives as PAS and CAS Inhibitors of Cholinesterases: Insights for Future Drug Design
resolves10.1016/j.jmgm.2016.11.013
The effects of fluorine substitution on the chemical properties and inhibitory capacity of Donepezil anti-Alzheimer drug; density functional theory and molecular docking calculations
resolves10.1016/0006-2952(61)90145-9
A new and rapid colorimetric determination of acetylcholinesterase activity
resolves10.3390/ijms22084145
Chromeno[3,4-b]xanthones as First-in-Class AChE and Aβ Aggregation Dual-Inhibitors
resolves10.1107/S0021889893002018
Crystal handling at low temperatures
resolves10.1107/S1600576714022985
Comparison of silver and molybdenum microfocus X-ray sources for single-crystal structure determination
resolves10.1107/S2053273314026370
<i>SHELXT</i>– Integrated space-group and crystal-structure determination
resolves10.1107/S2053229614024218
Crystal structure refinement with<i>SHELXL</i>
resolves10.1107/S0021889811043202
<i>ShelXle</i>: a Qt graphical user interface for<i>SHELXL</i>
resolves10.1107/S0021889808042726
<i>OLEX2</i>: a complete structure solution, refinement and analysis program
resolves10.1186/1758-2946-3-33
Open Babel: An open chemical toolbox
resolves10.1002/jcc.21334
AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
resolves10.1002/jcc.20084
UCSF Chimera—A visualization system for exploratory research and analysis
resolves10.1093/nar/gkab294
PLIP 2021: expanding the scope of the protein–ligand interaction profiler to DNA and RNA
The 10 references without a DOI — listed, not checked
no DOI — not checkedComprehensive Heterocyclic Chemistry IV
no DOI — not checkedPurification of Laboratory Chemicals
no DOI — not checkedData Collection Software Version 2016.9-0
no DOI — not checkedRemote Monitoring and Control, Version 1.451
no DOI — not checkedData Integration Engine v. 8.37a©
no DOI — not checkedRigaku. CrysAlis PRO, Rigaku V1.171.142.173a; Oxford Diffraction Ltd: England, 2022.
no DOI — not checkedDIAMOND, Version 3.2f
no DOI — not checkedDocker: Lightweight Linux Containers for Consistent Development and Deployment | Linux Journal. https://www.linuxjournal.com/content/docker-lightweight-linux-containers-consistent-development-and-deployment (accessed Jan 5, 2023).
no DOI — not checkedref69/cit69
no DOI — not checkedGitHub - donlnz/nonconformist: Python implementation of the conformal prediction framework. https://github.com/donlnz/nonconformist (accessed Jan 5, 2023).
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-24 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1021/acschemneuro.4c00241"><img src="https://citestamp.com/citestamped/10.1021/acschemneuro.4c00241/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1021/acschemneuro.4c00241/badge.svg)](https://citestamp.com/citestamped/10.1021/acschemneuro.4c00241)